The pursuit of market outperformance leads investors to the practice of hand-picking stocks. Skillful choices can be a catalyst for significant wealth enhancement.
The closing price of Myriad Genetics, Inc (NASDAQ: MYGN) was $6.02 for the day, up 3.26% from the previous closing price of $5.83. In other words, the price has increased by $3.26 from its previous closing price. On the day, 1.01 million shares were traded. MYGN stock price reached its highest trading level at $6.1 during the session, while it also had its lowest trading level at $5.805.
Ratios:
Our analysis of MYGN’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 1.28 and its Current Ratio is at 1.42. In the meantime, Its Debt-to-Equity ratio is 0.40 whereas as Long-Term Debt/Eq ratio is at 0.22.
Wells Fargo Downgraded its Overweight to Equal Weight on May 07, 2025, while the target price for the stock was maintained at $6.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Oct 11 ’24 when DIAZ PAUL J sold 15,000 shares for $22.93 per share. The transaction valued at 343,950 led to the insider holds 962,378 shares of the business.
DIAZ PAUL J bought 15,000 shares of MYGN for $343,950 on Oct 11 ’24. On Sep 11 ’24, another insider, DIAZ PAUL J, who serves as the President and CEO of the company, sold 15,000 shares for $26.72 each. As a result, the insider received 400,800 and left with 977,378 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, MYGN now has a Market Capitalization of 560128512 and an Enterprise Value of 640328640. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.67 while its Price-to-Book (P/B) ratio in mrq is 1.44. Its current Enterprise Value per Revenue stands at 0.769 whereas that against EBITDA is -35.974.
Stock Price History:
The Beta on a monthly basis for MYGN is 1.87, which has changed by -0.7822785 over the last 52 weeks, in comparison to a change of 0.1513431 over the same period for the S&P500. Over the past 52 weeks, MYGN has reached a high of $29.30, while it has fallen to a 52-week low of $3.76. The 50-Day Moving Average of the stock is 17.05%, while the 200-Day Moving Average is calculated to be -36.49%.
Shares Statistics:
MYGN traded an average of 1.94M shares per day over the past three months and 1498620 shares per day over the past ten days. A total of 93.10M shares are outstanding, with a floating share count of 88.12M. Insiders hold about 5.19% of the company’s shares, while institutions hold 97.85% stake in the company. Shares short for MYGN as of 1753920000 were 8498678 with a Short Ratio of 4.38, compared to 1751241600 on 7482557. Therefore, it implies a Short% of Shares Outstanding of 8498678 and a Short% of Float of 12.83.
